Topic: European Union
European Parliament President Jerzy Buzek said on Wednesday he was against genetically-modified foods but said they were an unavoidable part of the future.Asked by students in Sofia whether he was against GM foods, after the EU approved their cultivation, he said:GM foods ...
The European Commission on Tuesday approved the cultivation of genetically-modified potatoes, prompting an angry response from environmental campaign groups and two EU member governments.The first approval of genetically modified foods in Europe for 12 years was criticised by Greenpeace and Friends of ...
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence ...
Patent deals between generic and branded drug makers have been getting lot of attention lately on both sides of the Atlantic. Today, Pfizer took a turn in the spotlight.. Pfizer said that its record is clean and that it's cooperating with European ...
EU says it suspects Denmark's Lundbeck may have blocked launch of generic antidepressantsEuropean Union regulators said Thursday that they suspect Danish drug maker Lundbeck may have delayed the launch of a cheaper, generic version of its antidepressant drug in Europe.The European Commission ...
PARIS (Reuters) - More research is needed into Monsanto's genetically modified maize MON 810, the only biotech crop commercially grown in Europe, to assess its environmental impact, a French advisory body said.The opinion given by biotech committee HCB, published on Tuesday, was ...
European Union antitrust regulators said they made surprise raids on the offices of drug makers in several European nations Wednesday to seek evidence that they struck anticompetitive business deals or used a dominant market position to squeeze rivals.They did not name the ...
European Union antitrust regulators said they made surprise raids on the offices of drug makers in several European nations Wednesday to seek evidence that they struck anticompetitive business deals or used a dominant market position to squeeze rivals. The EU concluded a ...
TEVA), today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in ...
Parma, Italy, The Chiesi Group, which is based in Parma, ranks top among Italian investors in and Development within the pharmaceutical sector, putting it in eighth place in the ranking of the biggest national groups from all sectors, and in thirteenth place ...